MTAP and neoplasm: In normal, non-tumor cells, when MTA, or another MTAP substrate, 5′-deoxyadenosine (5′-dAdo), is present in sufficient amount, the abundant adenine produced from these substrates, by the action of MTAP, competes with these analogs for phosphoribosylation by APRT and the cells are protected from toxicity.